I am a market access professional with more than 16 years of experience in consultancy and international biotech and pharmaceutical companies. My clients profit from in-depth experience in strategic market access management and operational implementation. I advise clinical-stage companies regarding European market access processes and pricing and I support the launch of new therapeutic agents. I have proven competence in multiple indications, particularly in rare diseases, oncology, immunology, cardiovascular, neurology and genetic disorders. To the benefit of my customers I have a broad network and a sound expertise in preparation of HTA processes throughout Europe as well as in preparation and execution of effective negotiation and contracting strategies with payers. I am a Political Scientist (Master of Arts, University of Heidelberg) and hold a postgraduate degree in Market Access Management (EBS University of Business and Law, EBS European Business School, Wiesbaden/Oestrich-Winkel). Additionally, I am a certified Qualified Negotiator (Schranner Negotiation Institute, Zurich).